Quince Therapeutics
QNCX
QNCX
36 hedge funds and large institutions have $6.96M invested in Quince Therapeutics in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
27% less capital invested
Capital invested by funds: $9.55M → $6.96M (-$2.6M)
Holders
36
Holding in Top 10
–
Calls
$79K
Puts
$4K
Top Buyers
| 1 | +$1.07M | |
| 2 | +$245K | |
| 3 | +$70.9K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$53.7K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$49K |
Top Sellers
| 1 | -$136K | |
| 2 | -$123K | |
| 3 | -$30.8K | |
| 4 |
Morgan Stanley
New York
|
-$30.8K |
| 5 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$28.7K |
